UK Stock Market Today: FTSE 100 Futures Firm On Strong PMIs And Budget Focus

Top Losers

• Trustpilot Group (LSE:TRST)Trustpilot Group declined 5.59%.

• Seplat Energy (LSE:SEPL)Seplat Energy declined 2.84%.

• Canal+ (LSE:CAN)Canal+ declined 2.80%.

On The Radar

For UK investors this week is all about a cluster of big bank and energy earnings around Thursday and Friday, plus fresh housing and credit data that interact directly with the Bank of England's rate stance.

• HSBC HoldingsTue 27 Oct. Q3 2026 results land against a backdrop of firmer UK PMIs, so commentary on loan demand and deposit pricing offers a clearer view of how higher borrowing costs are affecting one of the UK's key lenders.

• Standard CharteredWed 28 Oct. The Q3 2026 update focuses attention on profit trends in Asia and emerging markets, which matter for UK holders because swings in those regions often influence the group's capital flexibility and dividend capacity in London.

• Lloyds Banking GroupThu 29 Oct. Q3 2026 earnings at 7:00 AM put UK retail credit in focus, with net interest margin and any change in mortgage arrears sitting alongside Friday's housing data when considering pressure on domestic borrowers.

• ShellThu 29 Oct. The Q3 2026 numbers will highlight cash flow and shareholder distributions, with UK energy stocks already sensitive to crude price headlines and UK fiscal debate around energy-related taxes.

• BoE Consumer Credit and Mortgage ApprovalsThu 29 Oct. September consumer credit at a consensus £2.2b and mortgage approvals expected near 54,300 help to indicate whether stronger October PMIs are associated with a pickup in borrowing, which would tend to limit expectations of rate cuts and support moves in the pound.

Sector & Industry Watch

Oil and Gas: Politics and PMIs pull in opposite ways

Oil and Gas has extended its recent positive run over the past week, helped by firmer UK PMI readings and a still supportive 7 day sector return. At the same time, Ithaca Energy is under pressure as the £8.7b Rosebank project faces possible rejection, while Jersey Oil and Gas gained comfort from government approval at Jackdaw.

For anyone holding UK producers, the swing factor is how the Autumn Budget handles North Sea taxes and approvals, since that mix directly shapes cash flows, future drilling and potentially dividend policies.

Real Estate: Gradual recovery meets portfolio reshaping

Real Estate has nudged higher over seven days and sits modestly ahead over the past month, which contrasts with a slightly softer GB Market in the same short window. In the background, Grit Real Estate is selling assets to shore up its balance sheet, while Dar Global is talking about new high end projects abroad.

If you own UK property trusts or housebuilders, the clearest catalyst is Thursday's Bank of England mortgage approvals data, because any sign of softer loan volumes would remind investors that higher borrowing costs still bite into housing demand.

Utilities: Income seekers watch water shake up

Utilities has moved higher over the past week and month, although individual stocks are telling very different stories. Pennon's £550m rights issue and dividend reset hit that share price hard, while peers like SSE have been dragged by broader sector weakness when energy names fall out of favour.

For income focused portfolios, the key thing to track is how Ofwat and the government respond to higher investment plans from water companies, since tighter rules or bigger spending requirements can affect future dividend headroom across the UK utilities sector.

Tech: AI orders support sector even as prices cool

Tech as a whole has eased back over the past week, yet the underlying story is more upbeat than that headline suggests. Computacenter just raised profit guidance on the back of a record AI infrastructure order backlog, and Kainos and Catenai also reported encouraging contract and customer news.

If you hold UK technology funds, the next real test is Computacenter's and peers' outlook commentary around the UK Autumn Budget and global rate decisions, since corporate IT spending plans and financing costs together shape how sustainable this AI driven demand looks for London listed tech groups.

Pharmaceuticals & Biotech: Trial news offsets funding stress

Pharmaceuticals & Biotech has pushed higher over the past week, supported by fresh clinical data from HUTCHMED and ongoing oncology work tied to AstraZeneca collaborations. At the other end of the spectrum, Sareum's discounted £3.2m fundraise and share price drop show how expensive it can be for smaller developers to keep trials moving.

For healthcare investors, the near term focus is on upcoming expert events and regulatory signals around savolitinib and other late stage assets, because green lights there would reinforce the idea that this sector's revenue potential is less tied to UK consumer demand than many others in the market.

Where Are The Opportunities Now?

With UK utilities responding to regulator pressure and income in focus, start with this list of 224 dividend fortresses if dependable payouts are the part of the story you care about most.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com